Phase 2 Readout
FDMT: Phase 2 Readout: 150
June 30, 2026 · 150. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- June 30, 2026
- Company
- 4D Molecular Therapeutics, Inc. (FDMT)
- Drug
- 150
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout~quarter
Phase 2 Readout: 150
- Drug
- 150
- Indication
- wet AMD